Global Gastrointestinal Therapeutics Market Size & Outlook
Global gastrointestinal therapeutics market, 2021-2033 (US$M)
Related Markets
Global gastrointestinal therapeutics market highlights
- The global gastrointestinal therapeutics market generated a revenue of USD 42,749.8 million in 2025 and is expected to reach USD 51,454.3 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 2.3% by 2033.
- In terms of segment, branded accounted for a revenue of USD 28,505.3 million in 2025.
- Generics is the most lucrative drug type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 42,749.8 million |
| Market revenue in 2033 | USD 51,454.3 million |
| Growth rate | 2.3% (CAGR from 2026 to 2033) |
| Largest segment | Branded |
| Fastest growing segment | Generics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Branded, Generics |
Other key industry trends
- In terms of revenue, the North America accounted for 38.0% of the global gastrointestinal therapeutics market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 4,394.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gastrointestinal Therapeutics Market Scope
Gastrointestinal Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Janssen Pharmaceuticals | View profile | 1-10 | Titusville, New Jersey, United States, North America | https://www.xarelto-us.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Organon & Co Ordinary Shares | View profile | 10000 | 30 Hudson Street, Floor 33, Jersey City, NJ, United States, 07302 | https://www.organon.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| Gilead Sciences Inc | View profile | 18000 | 333 Lakeside Drive, Foster, CA, United States, 94404 | https://www.gilead.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Global gastrointestinal therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gastrointestinal therapeutics market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 66.68% in 2025. Horizon Databook has segmented the Global gastrointestinal therapeutics market based on branded, generics covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Gastrointestinal Therapeutics Drug Type Outlook (Revenue, USD Million, 2021-2033)
- Branded
- Generics
- Global Gastrointestinal Therapeutics Drug Class Outlook (Revenue, USD Million, 2021-2033)
- Proton Pump Inhibitors
- Aminosalicylates
- H2 Antagonists
- Anti-diarrheals
- Laxatives
- Digestive Enzymes
- Anti-emetics
- Biologics/Biosimilar
- Others Drug Classes
- Global Gastrointestinal Therapeutics Route of Administration Outlook (Revenue, USD Million, 2021-2033)
- Others Route of Administrations
- Injectables
- Oral
- Global Gastrointestinal Therapeutics Application Outlook (Revenue, USD Million, 2021-2033)
- Ulcerative colitis
- Others Application
- Crohn's disease
- GERD
- IBS
- Global Gastrointestinal Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Reasons to subscribe to Global gastrointestinal therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global gastrointestinal therapeutics market databook
-
Our clientele includes a mix of gastrointestinal therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global gastrointestinal therapeutics market, including forecasts for subscribers. This global databook contains high-level insights into Global gastrointestinal therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global gastrointestinal therapeutics market size, by regions, 2021-2033 (US$M)
Top 10 countries: Gastrointestinal therapeutics market size, 2025 (US$M)
Global gastrointestinal therapeutics market share, by drug type, 2025 & 2033 (%, US$M)
Gastrointestinal therapeutics market: Opportunity assessment by country
Global gastrointestinal therapeutics market, by region, 2025 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
